Latest Ratings for VYGR
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2021 | Chardan Capital | Maintains | Neutral | |
| Oct 2021 | Baird | Upgrades | Neutral | Outperform |
| Jun 2021 | Compass Point | Initiates Coverage On | Buy |
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 4 Analysts
